Microcapsule-loading exosomes to treat vitreoretinal diseases
Scientists have developed ExoCaps, self-healing microcapsules that are more feasible than other cell-based technologies.
List view / Grid view
Scientists have developed ExoCaps, self-healing microcapsules that are more feasible than other cell-based technologies.
Lactate producing bacteria is responsible for rewiring metabolic signalling pathways, causing resistance to radiation therapy.
Extracellular vesicles loaded with mRNA encoding interferon-gamma offers promise for treating difficult tumours.
New research presented at the European Academy of Dermatology and Venereology (EADV) Congress 2023 in Berlin, Germany, has highlighted a previously underestimated aspect of acne's impact on individuals: its profound influence on social perception.
Bacteria programmed to paint targets on solid tumours for T cells to see eliminates the need for specific antigens.
Discovery about Huntington’s disease may apply to other neurodegenerative disorders, like Alzheimer’s and frontotemporal dementia.
The sensation of itch is something everyone has experienced at some point in their lives. It's a natural response to various irritants, from insect bites to dry skin. But what happens when the urge to itch becomes relentless, causing discomfort and, in some cases, serious health problems?
A recent scientific collaboration, led by the Institute of Nuclear Physics of the Polish Academy of Sciences, has overcome measurement challenges, enabling reliable cancer diagnosis.
Researchers designed the first magnetoelectric material that precisely stimulates neurons to treat nerve damage.
Research into how the amino acid arginine drives metabolic reprogramming offers promise for liver cancer treatment.
A new discovery about a different protective genetic mutation in apolipoprotein L1 could have major implications for kidney health.
New research improves patient care by finding where gene copies integrate into DNA and using lentiviral vectors.
In an exclusive interview with Nikki Carter at Molecular Devices, we explore the the power of patient-derived organoids (PDOs) in drug discovery.
CRISPR-DREAM tool used to activate insufficiently expressed genes and convert skin cells to induced pluripotent stem cells (iPSCs).
16 October 2023 | By Bruker Daltonics
Gain comprehensive insights into screening potential drugs, manipulating drug targets at the molecular level and employing techniques like SPR and X-ray crystallography for studying molecular interactions.